@article {Harmoinen:February 2003:0305-7453:361,
	author = "Harmoinen, Jaana",
	author = "Vaali, Kirsi",
	author = "Koski, Pertti",
	author = "Syrjanen, Kaisa",
	author = "Laitinen, Outi",
	author = "Lindevall, Kai",
	author = "Westermarck, Elias",
	title = "Enzymic degradation of a -lactam antibiotic, ampicillin, in the gut: a novel treatment modality",
	journal = "Journal of Antimicrobial Chemotherapy",
	volume = "51",
	year = "February 2003",
	abstract = "Antibiotics can cause severe alterations in the gut microflora and promote diarrhoea and overgrowth of pathogenic bacteria. The present study investigated the potency of targeted recombinant &#946;-lactamase (TRBL) to degrade a &#946;-lactam antibiotic in the jejunum of fistula-operated beagles. We used different peroral doses of purified &#946;-lactamase (PenP) of <I>Bacillus licheniformis</I> in enteric-coated pellets together with intravenous ampicillin. Serum and jejunal samples were collected for ampicillin and &#946;-lactamase analysis. A dose&#8211;response effect of TRBL on ampicillin concentrations in the jejunal samples could be observed. The highest doses applied decreased the jejunal ampicillin concentrations to undetectable levels. In the serum samples, the ampicillin concentrations were not affected by the &#946;-lactamase dose used. Our results indicate that it may be possible to evolve a targeted treatment to degrade &#946;-lactam antibiotics intestinally and, thus, decrease antibiotic-induced adverse effects on the gut microflora.",
	pages = "361-365(5)",
	url = "http://www.ingentaconnect.com/content/oup/janmic/2003/00000051/00000002/art00361"
	doi = "doi:10.1093/jac/dkg095"
}